Apollo Hospitals, TataMD collaborate to launch 'TataMD CHECK' test for COVID-19 in India
TataMD CHECK is a COVID-19 diagnostic test based on the DNA genome editing tool CRISPR Cas-9. The technology ensures quicker results due to a more agile process and AI-based automated result detection methodology
Apollo Hospitals, Tata MD partners to roll out paper-strip tests for Covid-19
Apollo Hospitals on Thursday announced a collaboration with Tata Medical and Diagnostics (Tata MD), the wholly owned healthcare venture from the Tata 
Hold Apollo Hospitals; target of Rs 2310: ICICI Direct
ICICI Direct recommended hold rating on Apollo Hospitals with a target price of Rs 2310 in its research report dated November 13, 2020.
Earnings Call for Q2FY21 of Apollo Hospitals Enterprise
Conference Call with Apollo Hospitals Enterprise Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Ms. Suneeta Reddy – Managing Director Dr. Hariprasad – President, Hospitals Division Mr. A. Krishnan - Chief Financial Officer
Apollo Hospitals Q2 net drops 30% to Rs 60 crore; board approves raising Rs 1,500 crore
Revenues for the second quarter declined by 3 percent to Rs 2,760.7 crore as against Rs 2,840.7 crore in the year-ago period, Apollo Hospitals Enterprise said in a statement. APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Limited Review Report On Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2020 With UDIN
In continuation of the Company's unaudited financial results for the quarter and six months ended September 30, 2020 ('the Results') filed with the stock exchanges today, please find attached the auditor's Limited Review Report on the Results, with Unique Document Identification Number ('UDIN'). APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Outcome Of The Board Meeting - 11Th November 2020
Decisions of the Board Meeting APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Financial Results For The Quarter And Half Year Ended 30Th September 2020
Financial results for the quarter and half year ended 30th September 2020 - enclosed